HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Commissioner Henney

This article was originally published in The Rose Sheet

Executive Summary

Official swearing-in ceremony will take place Dec. 15 at the White House. Vice President Al Gore and Health & Human Services Secretary Donna Shalala are expected to attend. In a brief introductory address to the agency on Nov. 30, Henney's first official day on the job, the commissioner stated that agency priorities will implement the "letter and spirit" of the FDA Modernization Act and strengthen the scientific base of the agency's decision-making procedures. Henney complimented staffers for the work done under Acting Commissioner Michael Friedman, MD, noting that "many things have been accomplished" in the interim administration

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel